[1] [1] JANG Y, BOO S, YOOH. Hepatitis B virus infection:fatigue-associated illness experiences among koreans［J］. Gastroenterology Nursing, 2018, 41(5): 388-395.

[2] [2] TREPO C, CHAN H L, LOK A, Hepatitis B virus infection［J］. Lancet, 2014, 384(9959): 2053-2063.

[3] [3] OTT J J, STEVENS G A, GROEGER J, et al. Global epidemiology of hepatitis B virus infection:new estimates of age-specific HBsAg seroprevalence and endemicity［J］. Vaccine, 2012, 30(12): 2212-2219.

[4] [4] KIM S H, KIM J W, LEE K L, et al. Hepatitis B virus infection is independently associated with advanced colorectal adenoma［J］. The American Journal of The Medical Sciences, 2018, 356(2): 141-146.

[5] [5] BAHRAM S, BRESNAHAN M, GERAGHTY D E, et al. A second lineage of mammalian major histocompatibility complex class I genes［J］. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91(14): 6259-6263.

[6] [6] GLAS J, MARTIN K, BRUNNLER G, et al. MICA, MICB and C1_4_1 polymorphism in Crohn’s disease and ulcerative colitis［J］. Tissue Antigens, 2001, 58(4): 243-249.

[7] [7] KIMURA T, GOTO K, YABUKI K, et al. Microsatellite polymorphism within the MICB gene among Japanese patients with Behcet’s disease［J］. Human Immunology, 1998, 59(8): 500-502.

[8] [8] LU M, XIA B, LI J, et al. MICB microsatellite polymorphism is associated with ulcerative colitis in Chinese population［J］.Clinical Immunology, 2006, 120(2): 199-204.

[9] [9] GONG Z, LUO Q Z, LIN L, et al. Association of MICA gene polymorphisms with liver fibrosis in schistosomiasis patients in the Dongting Lake region［J］.Brazilian Journal of Medical and Biological Research, 2012, 45(3): 222-229.

[10] [10] CHEN E, LIN L, CHEN C J, et al. MIC gene polymorphism and haplotype diversity in Zhuang nationality of Southern China［J］. Human Immunology, 2014, 75(9): 953-959.

[11] [11] LIN L, YANG W, CHEN E, et al. MIC gene polymorphism and haplotype diversity in Li nationality of Southern China［J］.Tissue Antigens, 2015, 85(1): 45-49.

[12] [12] LOK A S, MCMAHON B J. Chronic hepatitis B: update 2009［J］. Hepatology, 2009, 50(3): 661-662.

[13] [13] SANAGAWA A, HOTTA Y, KATAOKA T, et al. Hepatitis B infection reported with cancer chemotherapy:analyzing the US FDA adverse event reporting system［J］. Cancer Medicine, 2018, 7(6): 2269-2279.

[14] [14] DE FRANCHIS R, HADENGUE A, LAU G, et al. EASL international consensus conference on hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement(long version)［J］. Journal of Hepatology, 2003, 39: 3-25.

[15] [15] WANG Yuting, CHEN Taoying, ZHU Jian, et al. Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China［J］. Chinese Journal of Preventive Medicine, 2018, 52(4): 402-408.

[16] [16] ZHAO J, JIANG Y, LEI Y, et al. Functional MICA-129 polymorphism and serum levels of soluble MICA are correlated with ulcerative colitis in Chinese patients［J］. Journal of Gastroenterology and Hepatology, 2011, 26(3): 593-598.

[17] [17] GARCIA G, DEL P F, PEREZ A B, et al. Association of MICA and MICB alleles with symptomatic dengue infection［J］. Human Immunology, 2011, 72(10): 904-907.

[18] [18] DHODAPKAR K M, CIRIGNANO B, CHAMIAN F, et al. Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion［J］.International Journal of Cancer, 2004, 109(6): 893-899.

[19] [19] DHODAPKAR K M, CIRIGNANO B, CHAMIAN F, et al. Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion［J］.International Journal of Cancer, 2004, 109(6): 893-899.

[20] [20] ZHAO S, WANG H, NIE Y, et al. Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity［J］. Cancer Immunology Immunotherapy, 2012, 61(10): 1745-1753.